• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Stupid Cancer CEO Says Digital Health Innovators Must Seek, Incorporate Patient Input to Succeed

by Fard Johnmar 06/18/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Stupid Cancer CEO Says Digital Health InnovatorsMatthew Zachary, patient activist and founder and CEO of Stupid Cancer says digital health innovators must seek and incorporate patient input to succeed.

In May 2014, my firm, Enspektos, LLC held a unique 3-day all-Web conference, digihealth pulse Virtual 2014 (DHPV 2014).  During the event, more than 25 innovators, entrepreneurs, patients and others came together to provide useful and actionable insights, data and advice to health executives who attended the conference.  DHPV 2014 was unique, in part, because it was a fully virtual event, meaning that participants could attend sessions from wherever they were in the world on their schedule.  Another, and more important feature of DHPV 2014 was that we sought and highlighted a number of patients during the event so they could share their wisdom with attendees.

One of the patient speakers featured during the event was Matthew Zachary, CEO and founder of the non-profit Stupid Cancer. For nearly a decade, Stupid Cancer has focused on an important, but previously ignored, segment of cancer patients and survivors: young adults.  Cancer was — and in certain circles continues — to be considered a disease that primarily strikes older people. However, youth including teenagers, are regularly diagnosed with cancer each year.  Unfortunately, they often don’t receive the support and attention they need.  Stupid Cancer was founded to fill this void.

In addition to leading Stupid Cancer, Zachary has a rich history of advising companies like Google (during its Google Health days), large health organizations and others about technology.  He also has developed digital health tools, including a new mobile health application, Instapeer, designed to provide young cancer patients with a means of connecting quickly and privately with others coping with cancer.  Given this rich experience with digital health and his status as a cancer survivor, Zachary is in an ideal position to provide much-needed advice to innovators seeking to develop tools and technologies that will help patients better manage and understand their health.

In an effort to achieve DHPV 2014’s primary mission, which is to unleash the digital health innovation virus, we are producing a series of short videos featuring commentary and wisdom shared by speakers during the event.  The first installment of this video series, DHPV 2014 Shorts, features Zachary sharing his unique and uncensored thoughts about why so many digital health tools have been unsuccessful and what innovators should do about it. Hint: think less about technology and more about the end-user.  Click the image below to watch this video.

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |